These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2203562)

  • 21. [Circadian variations in the incidence of transient ischemic myocardial episodes during hospitalization for acute myocardial infarct].
    Astorri E; Garini A; Emanuelli C; De Chiara F; Distante S
    Minerva Cardioangiol; 1993 Sep; 41(9):377-81. PubMed ID: 8259233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Silent myocardial ischemia].
    Swidnicka-Szuszkowska B
    Pol Merkur Lekarski; 1999 Oct; 7(40):153-8. PubMed ID: 10835903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Consequences of circadian variability for the treatment of ischemic heart disease].
    Herren T; Urban P; Rutishauser W
    Schweiz Rundsch Med Prax; 1992 Feb; 81(7):176-82. PubMed ID: 1535952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contemporary management of silent ischemia: the role of ambulatory monitoring.
    Solomon H; DeBusk RF
    Int J Cardiol; 2004 Sep; 96(3):311-9. PubMed ID: 15301883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Symptomless (silent) myocardial ischemia and its prognostic significance].
    Jánosi A; Kádár A; Hankóczy J; Fehér A; Arvay A
    Orv Hetil; 1989 Feb; 130(9):453-5. PubMed ID: 2927939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequency of silent myocardial ischemia with 12-lead ST segment monitoring in the coronary care unit: are there sex-related differences?
    Adams MG; Pelter MM; Wung SF; Taylor CA; Drew BJ
    Heart Lung; 1999; 28(2):81-6. PubMed ID: 10076107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Long-term prognosis of patients with silent ischemia].
    Righetti A; Podio V; Ratib O; Stucki V; Rutishauser W
    Schweiz Med Wochenschr; 1987 Oct; 117(43):1696-9. PubMed ID: 3423761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circadian variations in ischemic threshold and their relation to the occurrence of ischemic episodes.
    Benhorin J; Banai S; Moriel M; Gavish A; Keren A; Stern S; Tzivoni D
    Circulation; 1993 Mar; 87(3):808-14. PubMed ID: 8095188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of autonomic nervous system dysfunction on the circadian pattern of myocardial ischemia in diabetes mellitus.
    Zarich S; Waxman S; Freeman RT; Mittleman M; Hegarty P; Nesto RW
    J Am Coll Cardiol; 1994 Oct; 24(4):956-62. PubMed ID: 7930230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circadian patterns of myocardial ischemia.
    Fox K; Mulcahy D; Keegan J; Wright C
    Am Heart J; 1989 Nov; 118(5 Pt 2):1084-6; discussion 1086-7. PubMed ID: 2683700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circadian variations in myocardial ischemia. Implications for management.
    Pepine CJ
    JAMA; 1991 Jan; 265(3):386-90. PubMed ID: 1984540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prognostic and economic implications of a strategy to detect and treat asymptomatic ischemia: the Atenolol Silent Ischemia Trial (ASIST) protocol.
    Pepine CJ; Cohn PF; Deedwania PC; Gibson RS; Gottlieb SO; Handberg E; Hill JA
    Clin Cardiol; 1991 Jun; 14(6):457-62. PubMed ID: 1810681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rationale for treatment of silent myocardial ischemia: focus on nifedipine.
    Nesto RW
    Cardiovasc Drugs Ther; 1990 Aug; 4 Suppl 5():929-34. PubMed ID: 2076402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is silent myocardial ischemia clinically important? Does it have prognostic significance?
    Deedwania PC; Carbajal EV
    Postgrad Med; 1989 Nov; 86(7):99-105, 108-10. PubMed ID: 2813229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic implications of circadian variations in myocardial ischemia and related physiologic functions.
    Pepine CJ
    Am J Hypertens; 1991 Jul; 4(7 Pt 2):442S-448S. PubMed ID: 1680345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circadian variation of ambulatory myocardial ischemia. Triggering by daily activities and evidence for an endogenous circadian component.
    Krantz DS; Kop WJ; Gabbay FH; Rozanski A; Barnard M; Klein J; Pardo Y; Gottdiener JS
    Circulation; 1996 Apr; 93(7):1364-71. PubMed ID: 8641025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can we really justify the treatment of silent ischemia in 1992? No!
    Mulcahy D; Fox K
    Cardiovasc Drugs Ther; 1992 Apr; 6(2):125-9. PubMed ID: 1390322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circadian patterns of myocardial ischemia: pathophysiologic and therapeutic considerations.
    Gottlieb SO
    J Cardiovasc Pharmacol; 1988; 12 Suppl 7():S18-21. PubMed ID: 2467121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sudden death and silent myocardial ischemia.
    Sheps DS; Heiss G
    Am Heart J; 1989 Jan; 117(1):177-84. PubMed ID: 2911970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Indications for treatment of silent myocardial ischemia.
    Cohn PF
    Cardiovasc Drugs Ther; 1988 May; 2(1):67-9. PubMed ID: 3154696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.